Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

On the release of glutamate and aspartate in the basal ganglia of the rat: Interactions with monoamines and neuropeptides

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • HerreraMarschitz, M.
  • Goiny, M.
  • You, Z. B.
  • Meana, J. J.
  • Pettersson, E.
  • RodriguezPuertas, R.
  • Xu, Z. Q.
  • Terenius, Lars
  • Hokfelt, T.
  • Ungerstedt, U.

publication date

  • July 1997

journal

  • Neuroscience and Biobehavioral Reviews  Journal

abstract

  • Using highly sensitive analytical procedures, glutamate (Glu), aspartate (Asp) and several putative neurotransmitters and metabolites can be monitored simultaneously in the extracellular space of neostriatum, substantia nigra and cerebral cortex of the rat by in vivo microdialysis. Glu and Asp are found at sub-micromolar concentrations in all investigated brain regions. In order to ascertain their neuronal origin, we have extensively studied the sensitivity of extracellular Glu and Asp levels to: (i) K(+)-depolarization, (ii) Na(+)-channel blockade, (iii) removal of extracellular Ca2+, (iv) depletion of presynaptic vesicles, and (v) integrity of neuronal pathways. The relevance of these criteria for several neurotransmitters monitored simultaneously or in parallel experiments has also been examined. The functional interactions among different neuronal pathways in the basal ganglia are studied by using selective pharmacological treatments, administered systemically, or locally via intracerebral injections or the microdialysis perfusion medium. Immunohistochemical evidence for the existence of Glu and/or Asp neuronal pathways in the basal ganglia of the rat is presented, discussing especially new findings indicating the existence of a Glu-independent Asp system, intrinsic to the neostriatum of the rat. The clinical relevance of these interactions is discussed, focusing on the implications for the treatment of neurodegenerative disorders affecting the basal ganglia.

subject areas

  • Animals
  • Aspartic Acid
  • Basal Ganglia
  • Biogenic Monoamines
  • Glutamic Acid
  • Neuropeptides
  • Rats
scroll to property group menus

Research

keywords

  • Alzheimer's disease
  • Parkinson's disease
  • excitatory amino acids
  • immunocytochemistry
  • in vivo
  • microdialysis
  • monoamines
  • neuropeptides
  • psychosis
  • rat
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0149-7634

Digital Object Identifier (DOI)

  • 10.1016/s0149-7634(96)00033-4

PubMed ID

  • 9195607
scroll to property group menus

Additional Document Info

start page

  • 489

end page

  • 495

volume

  • 21

issue

  • 4

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support